CymoGen Dx, LLC

NEW WINDSOR, NY · Founded 2010 · CIK 0001495598 · Medtech · Acquired

FISH probes and reagents for genomic aberration identification

biocare.net →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$350K
1 Form D · Jul 2010
195 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$350,161
Form D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
928APO Technologies, Inc——
929Telcare, Inc.—$65M
930NeuroSigma, Inc.—$13M
931CymoGen Dx, LLC—$350K
932ADVANCED BIODEVICES LLC——
933VENTRIX INCORPORATED—$5.2M
934Long Bridge Medical, Inc.—$7.2M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 3 related persons
  • Allen GoodmanDirector
  • Peter HartmayerDirector · Executive Officer · Promoter
  • Andrew RogalDirector · Executive Officer · Promoter

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.